Recently, Jbara et al. reported that RBFOX2 acted as a metastatic suppressor in pancreatic cancer and discovered a signature of RBFOX2-regulated alternative splicing in metastatic pancreatic cancer (Jbara et al., 2023). This evidence concerns the gene RBFOX2 and familial pancreatic carcinoma.